AGILENT TECHNOLOGIES INC (A)
US00846U1016 - Common Stock
Taking everything into account, A scores 6 out of 10 in our fundamental rating. A was compared to 58 industry peers in the Life Sciences Tools & Services industry. A gets an excellent profitability rating and is at the same time showing great financial health properties. A has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
A had positive earnings in the past year.
In the past year A had a positive cash flow from operations.
A had positive earnings in each of the past 5 years.
Each year in the past 5 years A had a positive operating cash flow.
1.2 Ratios
A has a Return On Assets of 11.29%. This is amongst the best in the industry. A outperforms 91.38% of its industry peers.
The Return On Equity of A (19.97%) is better than 91.38% of its industry peers.
A has a Return On Invested Capital of 12.36%. This is amongst the best in the industry. A outperforms 93.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for A is above the industry average of 9.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.29% | ||
| ROE | 19.97% | ||
| ROIC | 12.36% |
ROA(3y)11.58%
ROA(5y)10.71%
ROE(3y)22.44%
ROE(5y)20.92%
ROIC(3y)14.34%
ROIC(5y)12.54%
1.3 Margins
With an excellent Profit Margin value of 18.35%, A belongs to the best of the industry, outperforming 91.38% of the companies in the same industry.
A's Profit Margin has improved in the last couple of years.
A has a Operating Margin of 19.47%. This is amongst the best in the industry. A outperforms 86.21% of its industry peers.
In the last couple of years the Operating Margin of A has grown nicely.
A's Gross Margin of 50.56% is in line compared to the rest of the industry. A outperforms 55.17% of its industry peers.
A's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.47% | ||
| PM (TTM) | 18.35% | ||
| GM | 50.56% |
OM growth 3Y8.56%
OM growth 5Y2.16%
PM growth 3Y10.45%
PM growth 5Y23.06%
GM growth 3Y-1.44%
GM growth 5Y-1.41%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so A is still creating some value.
The number of shares outstanding for A has been reduced compared to 1 year ago.
A has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, A has an improved debt to assets ratio.
2.2 Solvency
A has an Altman-Z score of 6.57. This indicates that A is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.57, A belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
The Debt to FCF ratio of A is 1.55, which is an excellent value as it means it would take A, only 1.55 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of A (1.55) is better than 91.38% of its industry peers.
A has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
A's Debt to Equity ratio of 0.41 is on the low side compared to the rest of the industry. A is outperformed by 65.52% of its industry peers.
Even though the debt/equity ratio score it not favorable for A, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | 1.55 | ||
| Altman-Z | 6.57 |
ROIC/WACC1.01
WACC12.19%
2.3 Liquidity
A Current Ratio of 2.68 indicates that A has no problem at all paying its short term obligations.
The Current ratio of A (2.68) is comparable to the rest of the industry.
A Quick Ratio of 2.04 indicates that A has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.04, A is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.04 |
3. Growth
3.1 Past
A shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The Earnings Per Share has been growing by 14.33% on average over the past years. This is quite good.
A shows a decrease in Revenue. In the last year, the revenue decreased by -2.81%.
A shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.82% yearly.
EPS 1Y (TTM)0%
EPS 3Y18.44%
EPS 5Y14.33%
EPS growth Q2Q-5.84%
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y8.57%
Revenue growth 5Y6.82%
Revenue growth Q2Q-5.58%
3.2 Future
The Earnings Per Share is expected to grow by 8.77% on average over the next years. This is quite good.
Based on estimates for the next years, A will show a small growth in Revenue. The Revenue will grow by 4.15% on average per year.
EPS Next Y2.95%
EPS Next 2Y6.74%
EPS Next 3Y7.79%
EPS Next 5Y8.77%
Revenue Next Year-0.63%
Revenue Next 2Y2.84%
Revenue Next 3Y4.06%
Revenue Next 5Y4.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 25.61 indicates a quite expensive valuation of A.
A's Price/Earnings ratio is rather cheap when compared to the industry. A is cheaper than 84.48% of the companies in the same industry.
A is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 22.15, A is valued on the expensive side.
86.21% of the companies in the same industry are more expensive than A, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.72. A is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.61 | ||
| Fwd PE | 22.15 |
4.2 Price Multiples
70.69% of the companies in the same industry are more expensive than A, based on the Enterprise Value to EBITDA ratio.
93.10% of the companies in the same industry are more expensive than A, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.44 | ||
| EV/EBITDA | 26.29 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates A does not grow enough to justify the current Price/Earnings ratio.
A has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)8.68
PEG (5Y)1.79
EPS Next 2Y6.74%
EPS Next 3Y7.79%
5. Dividend
5.1 Amount
With a yearly dividend of 0.69%, A is not a good candidate for dividend investing.
A's Dividend Yield is rather good when compared to the industry average which is at 0.65. A pays more dividend than 98.28% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, A's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
5.2 History
The dividend of A is nicely growing with an annual growth rate of 8.62%!
A has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.62%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
21.60% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
The dividend of A is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP21.6%
EPS Next 2Y6.74%
EPS Next 3Y7.79%
AGILENT TECHNOLOGIES INC
NYSE:A (5/2/2024, 7:04:00 PM)
After market: 137.52 0 (0%)137.52
-1.17 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap40.30B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.69% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.61 | ||
| Fwd PE | 22.15 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)8.68
PEG (5Y)1.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.29% | ||
| ROE | 19.97% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 19.47% | ||
| PM (TTM) | 18.35% | ||
| GM | 50.56% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.68 | ||
| Quick Ratio | 2.04 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)0%
EPS 3Y18.44%
EPS 5Y
EPS growth Q2Q
EPS Next Y2.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.81%
Revenue growth 3Y8.57%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y